The 26-week LIRA-SWITCH trial in adults assessed efficacy and safety of Victoza 1.8mg as an add-on to metformin in 407 adults with type 2 diabetes who switched from the DPP-4 inhibitor Januvia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback